Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/j.1525-1403.2008.00158.x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Practice choices and challenges in the current intrathecal therapy environment: an online survey.
Pain Med
March 2009
The Center for Pain Relief, Charleston, West Virginia, USA.
Objective: The objective of this study was to evaluate current practice characteristics, treatment choices, clinical experiences, and economic concerns associated with intrathecal therapy.
Design: Health care professionals in the United States, who were known to actively use intrathecal therapy in their practices, were recruited to participate in an online survey; contact information was obtained via Internet searches, university Websites, association memberships, industry databases, and personal contacts. Survey responses were summarized descriptively.
Future directions for intrathecal pain management: a review and update from the interdisciplinary polyanalgesic consensus conference 2007.
Neuromodulation
April 2008
Charleston, WV; San Francisco, CA; Houston, TX; Houston, TX; Huntington, WV; Bellevue, WA; Winston Salem, NC; Baltimore, MD; Napa, CA; Wilmington, DE; Chicago, IL; Columbus, OH; Cleveland, OH; Tampa, FL; Los Angeles, CA; Winston Salem, NC; Elkings Park, PA; Hattiesburg, MS; Colts Neck, NJ; Cleveland, OH; Scottsdale, AZ; Huntsville, AL; Lexington, KY; Iowa City, IA; Rochester, NY; Nieuwegein, The Netherlands; Boston, MA; La Jolla, CA; Switzerland; Australia; and Brugge, Belgium.
Background. Expert panels of physicians and nonphysicians, all expert in intrathecal (IT) therapies, convened in the years 2000 and 2003 to make recommendations for the rational use of IT analgesics, based on the preclinical and clinical literature known up to those times, presentations of the expert panels, discussions on current practice and standards, and the result of surveys of physicians using IT agents. An expert panel of physicians and nonphysicians has convened in 2007 to update information known regarding IT therapies and to update information on new and novel opioid and nonopioid analgesic compounds that might show promise for IT use.
View Article and Find Full Text PDFManagement of intrathecal catheter-tip inflammatory masses: an updated 2007 consensus statement from an expert panel.
Neuromodulation
April 2008
Charleston, WV; San Francisco, CA; Houston, TX; Houston, TX; Huntington, WV; Bellevue, WA; Winston Salem, NC; Baltimore, MD; Napa, CA; Wilmington, DE; Chicago, IL; Columbus, OH; Cleveland, OH; Tampa, FL; Los Angeles, CA; Winston Salem, NC; Elkings Park, PA; Hattiesburg, MS; Colts Neck, NJ; Cleveland, OH; Scottsdale, AZ; Huntsville, AL; Lexington, KY; Iowa City, IA; Rochester, NY; Nieuwegein, The Netherlands; Boston, MA; La Jolla, CA; Switzerland; Australia; and Brugge, Belgium.
Background. Expert panel of physicians and nonphysicians, all expert in intrathecal (IT) therapies, convened in the years 2000 and 2003 to make recommendations for the rational use of IT analgesics based on the preclinical and clinical literature known up to those times, presentations of the expert panel, discussions on current practice and standards, and the result of surveys of physicians using IT agents. An expert panel of physicians and convened in 2007 to review previous recommendations and to form recommendations for the rational use of IT agents as they pertain to new scientific and clinical information regarding the etiology, prevention and treatment for IT granuloma.
View Article and Find Full Text PDFImmunological responses in a patient with glioblastoma multiforme treated with sequential courses of temozolomide and immunotherapy: case study.
Neuro Oncol
February 2008
Department of Neurosurgery, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030-4009, USA.
Cytotoxic chemotherapy that induces lymphopenia is predicted to ablate the benefits of active antitumor immunization. Temozolomide is an effective chemotherapeutic agent for patients with glioblastoma multiforme, but it induces significant lymphopenia. Although there is monthly fluctuation of the white blood cell count, specifically the CD4 and CD8 counts, there was no cumulative decline in the patient described in this case report.
View Article and Find Full Text PDFBackground. Expert panels of physicians and nonphysicians in the field of intrathecal therapies convened in 2000 and 2003 to make recommendations for the rational use of intrathecal analgesics based on the preclinical and clinical literature known up to those times. An expert panel of physicians convened in 2007 to update previous recommendations and to form guidelines for the rational use of intrathecal opioid and nonopioid agents.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!